Building biosecurity for synthetic biology.

Molecular Systems Biology
Benjamin D TrumpIgor Linkov

Abstract

The fast-paced field of synthetic biology is fundamentally changing the global biosecurity framework. Current biosecurity regulations and strategies are based on previous governance paradigms for pathogen-oriented security, recombinant DNA research, and broader concerns related to genetically modified organisms (GMOs). Many scholarly discussions and biosecurity practitioners are therefore concerned that synthetic biology outpaces established biosafety and biosecurity measures to prevent deliberate and malicious or inadvertent and accidental misuse of synthetic biology's processes or products. This commentary proposes three strategies to improve biosecurity: Security must be treated as an investment in the future applicability of the technology; social scientists and policy makers should be engaged early in technology development and forecasting; and coordination among global stakeholders is necessary to ensure acceptable levels of risk.

Citations

Jan 7, 2021·PloS One·Luke KempWilliam J Sutherland

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

iGEM

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Revista de saúde pública
Agência Nacional de Vigilância Sanitária
International Journal of Medical Microbiology : IJMM
Reinhard Kurth
Molecular Therapy : the Journal of the American Society of Gene Therapy
Michael J Imperiale
Journal of the American Dietetic Association
Barbara Bruemmer
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science
Tara O'Toole, Thomas V Inglesby
© 2021 Meta ULC. All rights reserved